US Patent Issued to Donald Danforth Plant Science Center on April 21 for "Antimicrobial NCR2 peptides" (Missouri Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,600, issued on April 21, was assigned to Donald Danforth Plant Science Center (St. Louis).

"Antimicrobial NCR2 peptides" was invented by Dilip M. Shah (St. Louis) and Siva L. S. Velivelli (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antimicrobial nodule specific cysteine rich (NCR2) peptides and proteins are disclosed along with compositions comprising the NCR2 peptides or NCR2 proteins and transgenic or genetically edited plants or microorganisms that express the NCR2 peptides or proteins to inhibit growth of pathogenic microbes. Such NCR2 peptides, proteins, compositions, plants, and microorganisms can provide for inhibition of funga...